In the news: Bristol-Myers pays $14 million FCPA fine, Xiaomi gets investigated for advertising violations, Unisplendor acquires Western Digital stake

This week US drugmaker Bristol-Myers Squibb paid the SEC to settle China bribery charges, Xiaomi faced accusations of violating the new Advertising Law and Tsinghua Unigroup paid $3.8 billion for Western Digital shares

4 minute readOctober 07, 2015 at 09:47 AM

clpstaff

& clp articles

Bristol-Myers pays SEC $14 million for bribery in China

US drugmaker Bristol-Myers Squibb is paying $14 million to the US SEC to settle charges that its Chinese joint venture violated the FCPA by allegedly making improper payments to hospital

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)